US Patent 9775844 Heterocyclic compounds and uses thereof
Patent 9775844 was granted and assigned to Infinity Pharmaceuticals on October, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+300 characters)
Article
Patent abstract
Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09775844 Heterocyclic compounds and uses thereof US Patent 9775844 Heterocyclic compounds and uses thereof
Infobox
Patent Number
0977584400
Patent Number
977584400
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
097758440
Date of Patent
October 3, 2017
0Patent Application Number
146616560
Date Filed
March 18, 2015
0Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
097758440
Date of Patent
October 3, 2017
0Patent Application Number
146616560
Date Filed
March 18, 2015
0Patent Primary Examiner
Edits on 15 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09775844 Heterocyclic compounds and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09775844
Date of patent
October 3, 2017
Patent application number
14661656
Date Filed
March 18, 2015
Patent primary examiner
Find more entities like US Patent 9775844 Heterocyclic compounds and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
